Abgent, a WuXi AppTec company, is a leading provider of antibodies and related services for biomedical research and drug discovery.
Unsurpassed production capabilities allow Abgent annually to develop over 2,000 research use only antibodies directed against novel and well-established targets. Our competencies lie in the development of high quality antibodies and related reagents for the study of neurodegenerative diseases, stem cells, autophagy, and model organisms. Our antibodies are rigorously validated and optimized to ensure accurate and consistent performance.
Abgent also offers a broad range of custom antibody services, including our ELITE. Custom Service. This service, customized for drug discovery, delivers “customer driven” antibodies validated and optimized in customer defined applications, using either an Abgent or customer provided antigen, protocol, samples, or compound. Standard custom antibody services allow access to over a decade of experience in antigen design and antibody selection, validation, optimization and purification.
For more information, please visit Abgent website.